pro044
Nucleic acidexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01037309)
Timeline
Indications
Studied for
Mechanism of action
- DystrophinSupplementation
DMD supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bmn 044
- pro044
- pro044
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02958202 | Phase 2 | Apr 1, 2016 | Biomarin |
| NCT02329769 | Phase 2 | Dec 1, 2014 | Biomarin |
| NCT01037309 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2009 | Biomarin, Katholieke Universiteit Leuven, Leiden University, University of Gothenburg |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomarin | For profit | 3 | 3 | 1 | 2009 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1